ABSTRACT. The objective of this study was to determine if the transfection of human prourokinase (ProU) gene and passage number of transfected ear fibroblasts affected in vitro development of bovine transgenic nuclear transfer (NT) embryos. An expression plasmid for human ProU was constructed by inserting a bovine beta-casein promoter, a green fluorescent protein (GFP) marker and human ProU gene into a pcDNA3 plasmid and transfected into bovine ear fibroblasts using a lipid mediated method. Abattoir derived oocytes were enucleated at 18-20 hr post maturation and a single donor cell was transferred into the perivitelline space of a recipient oocyte. After fusion and activation, the couplets were cultured in modified synthetic oviductal fluid (mSOF) medium for 168 hr. In Experiment 1, significantly lower rate in blastocysts formation (10.3%) was observed in transfected donor cells at early passage than that in nontransfected counterparts (22.1%, P<0.05). In Experiment 2, development to blastocysts and GFP expression in blastocysts were not significantly different between early (3-7) and late (8-12) passage donor cells (10.3 vs. 11.3% and 54.5 vs. 41.7%, respectively). This study indicates that in vitro development of bovine transgenic NT embryos is negatively influenced by transfection of human ProU gene into donor fibroblasts. However, passage number of transfected ear fibroblasts does not affect in vitro development of bovine transgenic NT embryos. KEY WORDS: bovine ear fibroblast, in vitro development, passage number, transfection, transgenic nuclear transfer embryo.
Production of large volume of therapeutic proteins in milk of transgenic cows has a great value in the field of medicine [14] . Prourokinase (ProU) is the latest in a growing list of medicines being tested to dissolve clots in the brain and its main function is fibrinolysis [4] . To produce transgenic cows, somatic cell nuclear transfer (NT) technique is considered superior to other methods including pronuclear microinjection method [15, 20] . For production of transgenic embryos by somatic cell NT, transfection and selection of donor cell lines are performed before nuclear transfer. There are reports that in vitro development of bovine transgenic NT embryos is negatively influenced by the transfection of donor cells [1, 28] . In contrast, Roh et al. [22] reported no difference in in vitro development of bovine transgenic NT embryos reconstructed with either enhanced green fluorescent protein (EGFP) gene transfected or nontransfected fetal fibroblasts. This difference in developmental rates of transgenic embryos among the studies may be due to differences in vector construction for a desired gene and transfection methods used. However, to our knowledge, there is no report on effect of transfection of adult bovine ear fibroblasts with human ProU gene on in vitro development of bovine NT embryos.
For efficient production of transgenic animals, it will be preferable to have stable incorporation of exogenous genes in donor cell lines. To obtain stable incorporation of exogenous genes, donor cell lines should have potential to tolerate the insult of transfection and selection after prolonged culture with respect to culture period and cell passages. Moreover, prolonged culture of nuclear donor cells is essential for targeted genetic manipulation of donor cells such as "gene knock-out" [12] . There is report on difference in rate of in vitro development of bovine NT embryos between early and late passages ear fibroblasts as donor nuclei [12] . However, in vitro development of bovine transgenic NT embryos derived from transfected ear fibroblasts with respect to different passages has not yet been investigated. Therefore, the objective of this study was to determine whether the transfection of human ProU gene and passage number of transfected ear fibroblasts affected in vitro development of bovine transgenic NT embryos or not.
MATERIALS AND METHODS
Primary culture and transfection of ear fibroblasts: Ear tissues obtained from an adult Holstein cow (denoted as H213) were washed in Dulbecco's Phosfate Buffered Saline (DPBS; Life Technologies, Grand Island, NY) and minced with a surgical blade. The minced tissues were dissociated in Dulbecco's Modified Eagle Medium (DMEM; Life Technologies) supplemented with 0.25% (w/v) trypsin and 1 mM EDTA (Life Technologies) for 1 hr. Trypsinized cells were washed once by centrifugation at 300 × g for 10 min and subsequently seeded into 100 mm plastic culture dishes (Becton Dickinson, Franklin Lakes, NJ). Seeded cells were cultured for 6 to 8 days in DMEM supplemented with 10% (v/v) fetal bovine serum (FBS, Life Technologies), 1% (v/v) non-essential amino acids (Life Technologies), and 100 iu/ ml penicillin and 0.1 mg/ml streptomycin (Sigma Chemical Co., St Louis) at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. After removal of unattached clumps of cells or explants, attached cells were further cultured until (100%) confluency, and then subcultured at intervals of 5 to 7 days. An expression plasmid for human ProU (pbetaProU) was constructed by inserting a bovine beta-casein promoter (accession number: M55158.1), a green fluorescent protein (GFP) marker gene, and human ProU desired gene (accession number: X02419) into a pcDNA3 plasmid (Life Technologies). For transfection, ear fibroblasts were subcultured until 50-60% confluency in a 35 mm culture dish and transfected with the plasmid using FuGene6® (Roche Diagnostics Corporation, Indianapolis, IN) according to the manufacturer's instruction. The transfected cells were cultured for at least 3-4 days in order to induce chromosomal integration of transgene and 100% confluency of the cell. Before nuclear transfer, donor cells were collected by trypsinization and resuspended in DPBS supplemented with 0.5% FBS. GFP-expressing cells were selected under ultraviolet (UV) light using a standard fluorescent isothiocyanate (FITC; excitation wave length: 450-490 nm; Bmode filter, Nikon, Japan) filter set and used as donor nuclei.
Nuclear transfer: Somatic cell nuclear transfer was performed according to the method described by Cho et al. [7] . Briefly, after in vitro maturation of slaughter house derived cumulus-oocyte complexes (COCs) for 18-20 hr in TCM-199 (Life Technologies) supplemented with 10% FBS, COCs were denuded by repeated pipetting with a narrow fire-polished pipette in handling medium (HEPES-buffered CR2aa medium) [23] supplemented with 0.1% hyaluronidase (Sigma). Micromanipulation of the denuded oocytes was performed in 3-4 µl drops of handling medium supplemented with 10% FBS and 7.5 µg/ml cytochalasin B (Sigma) covered with mineral oil under differential interference contrast (DIC) microscopy (Nikon, Tokyo, Japan) equipped with micromanipulation system (Narishige, Tokyo, Japan). A slit was made in zona pellucida close to the first polar body with a glass needle and enucleation was performed by squeezing the oocyte to remove the first polar body with small volume of surrounding cytoplasm. For nuclear transfer, single GFP expressed cell was aspirated into the cell insertion pipette and inserted into the perivitelline space of the recipient oocyte through the same slit that was made during enucleation. Reconstructed couplets were electrically fused at 24 hr post maturation by inducing 2 DC pulses of 1.75 kV/cm for 15 µsec delivered by an electro-cell manipulator (BTX 2001, San Diego, U.S.A.) in calcium free mannitol medium. Activation of embryos was chemically performed by incubation in 5 µM ionomycin (Sigma) for 4 min followed by post-activation in 2 mM 6-dimethylaminopurine (Sigma) for 4 hr. Fusion rates were recorded under stereo microscope during washing after activation and confirmed by observing GFP expression in recipient cytoplasm under DIC microscopy equipped with FITC filter.
In vitro culture of reconstructed embryos: Five to 7 fused embryos were cultured in mSOF supplemented with 8 mg/ ml BSA [8] at 39°C with 5% CO 2 , 5% O 2 and 90% N 2 under humidified condition. The cleavage and blastocyst formation rates were recorded at 48 hr and 168 hr after activation, respectively. The GFP expression in blastocyst was determined under FITC filter. The blastocysts were considered as expressed blastocysts when GFP expression was observed in either whole or part of the blastocysts. When GFP expression was not observed in any part of the blastocysts, the blastocysts were considered as unexpressed blastocysts.
Experimental design: In Experiment 1, the effect of transfection of donor cells on in vitro development of transgenic NT embryos was determined. Transfected and nontransfected ear fibroblasts of same passage (3-7 passages) were used for comparison of embryo development. In Experiment 2, the effects of number of cell passages of transfected donor cells on in vitro development of NT embryos and GFP expression in blastocysts were examined. Transfected cells were cultured for at least 3-4 days and cell passages of transfected donor cells were divided into early (3-7) and late (8-12) passages groups before performing NT. The data for transfected donor cells in Experiment 1 was used as the data for early passage transfected cells in Experiment 2.
Statistical analysis: All data in each parameter were expressed as proportion and analyzed using a general linear model (PROC-GLM) in a SAS 8.12 program. Statistical significance was considered when the P value was less than 0.05.
RESULTS

Experiment 1:
Although the fusion rate was significantly higher (73.8%) in reconstructed embryos derived from transfected donor cells than that in embryos derived from nontransfected counterparts (62.8%, P<0.05), there was no significant difference in cleavage rates of embryos reconstructed with either transfected or nontransfected donor cells (69.2 vs. 64.0%, respectively; Table 1 ). However, significantly lower number of reconstructed embryos developed to blastocysts stage after performing NT using transfected ear fibroblasts than that used nontransfected counterparts (10.3 vs. 22.1%; P<0.05).
Experiment 2: The effect of passage number of transfected ear fibroblasts on development of transgenic NT embryos is shown in Table 2 . There were no significant differences between embryos derived from either early (3-7) or late (8) (9) (10) (11) (12) passage donor cells in rates of fusion (73.8 vs. 65.0%), cleavage (69.2 vs. 56.6%), blastocysts formation (10.3 vs. 11.3%) and GFP expression in blastocysts (54.5 vs. 41.7%, respectively). In average, the GFP expression in blastocysts was 47.8% (11 out of 23). GFP expression was observed in embryos of all stages of development from 2-cell to blastocysts with some mosaic expression. However, the data on mosaic expression were not recorded.
DISCUSSION
Production of transgenic cloned cows to produce human ProU as a therapeutic protein has a great value in the field of medicine. In the present study, the effects of ProU gene transfection and passage number of transfected ear fibroblasts on in vitro development of bovine cloned embryos were evaluated. Although in vivo development of bovine transgenic NT embryos was not investigated by embryo transfer, the present study clearly demonstrated that bovine ear fibroblasts transfected with ProU gene yielded lower blastocysts development than nontransfected counterparts. However, passage number of transfected donor cells had no effect on in vitro development of transgenic embryos.
To produce transgenic animals by somatic cell NT technique, transfection and selection of cultured donor cells are important factors [27] . In the present study, in vitro development of bovine transgenic embryos was negatively affected by the transfection of a desired gene. This finding supports the earlier study in which lower in vitro development of NT embryos was obtained using bovine prochymosin gene transfected fetal fibroblasts [28] . Similarly, there are reports on lower development of transgenic NT embryos reconstructed with EGFP gene transfected donor cells in bovine [1] and porcine [16] . In contrast, there are reports to show no negative effect of EGFP gene transfection of fetal fibroblasts on development of transgenic embryos in bovine [22] , goats [10] and pigs [11] . Although, the reason for lower rate of development of transgenic NT embryos in our study has not been confirmed, repeated exposure to UV light to visualize the transfected cells during nuclear transfer might contribute to this [1] . Furthermore, it is possible that introduction of a foreign gene may interfere with the proper reprogramming of bovine transgenic NT embryos [21] .
Prolonged culture in terms of duration and passage number of transfected donor cells is essential for stable integration of transgene and selection of transfected cell lines before performing NT [27] . However, number of passages of transfected donor cells influenced the embryo development [2, 22, 24] . In the present study, ear fibroblasts up to 12 passages can be used for transfection of the ProU gene without any harmful effect on embryo development. On the contrary, development of bovine transgenic embryos was improved when reconstructed with granulosa cells with 15 passages [2] , but was depressed when reconstructed with fetal fibroblasts with 17-32 passages [22] . This variation in embryo development in different studies might be due to using of different genes, donor cells and NT techniques [28] .
For production of transgenic cells, various selection markers including antibiotics and GFP with different actions and advantages have been employed [5, 9] . Although antibiotics have successfully been used in generating transgenic cells, these induced cellular damage, senescence and chromosomal abnormality after long-term selection of somatic cells [9] . Since first introduced by Chalfie and colleagues in 1994, GFP is now emerged as a new selection marker because of its expression in a broad range of organism and no adverse biological effects [5] . In addition, the success in selecting and producing transgenic mice and pigs [6, 13, 19, 25] using GFP as a marker has paved the way for GFP in future transgenic experimentation. In this study, in order to produce transgenic NT embryos, we used a GFP gene as a selection marker and in average, 47.8% blastocysts expressed GFP under FITC filter with some mosaic expression. Similarly, GFP expression was not observed in all porcine transgenic NT embryos [17, 18] , and mosaic expression of GFP gene was shown in the embryos [18] . In contrast, GFP expression was observed in all transgenic NT blastocysts of bovine [1, 3] and porcine [26] with no mosaic expression. The reason for mosaic expression of GFP gene observed in this study is not known at this moment. Since GFP gene was expressed in all fused embryos, the GFP gene might not be properly expressed during transition from maternal genome to the embryonic genome resulting in absence of GFP expression in some blastocysts.
In conclusion, the present study indicates that in vitro development of bovine transgenic NT embryos is negatively influenced by transfection of human ProU gene into the ear fibroblasts. However, passage number of transfected ear fibroblasts does not affect the in vitro development of bovine transgenic NT embryos.
